Current Headlines

  1. EMD Millipore Introduces Incoming CEO And President

    EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, announces the appointment of Udit Batra, Ph.D. as its incoming President and CEO, responsible for the organization's strategic direction to drive growth and product innovation as well as oversight of the worldwide operations.

  2. Roche Acquires IQuum For Up To $450 Million

    Roche announced its acquisition of IQuum, Inc., a privately held company centered on developing point of care offers for the molecular diagnostics market.

  3. Teva And CRT Identify New Cancer Drug Candidate

    Teva and the Cancer Research Technology (CRT) announced a successful outcome to the organizations’ existing collaboration through the identification of a new atypical Protein Kinase C (aPKC) inhibitor pre-clinical candidate.

  4. AAVLife Formed To Advance Gene Therapy For Friedreich’s Ataxia

    The Friedreich's Ataxia Research Alliance (FARA) announced the birth of a new company, AAVLife, for the rapid development of a promising gene-therapy program for the treatment of cardiomyopathy in Friedreich’s Ataxia (FA).

  5. Amgen’s Melanoma Drug Study Misses Secondary Endpoint

    Amgen reported that the Phase III trial evaluating its melanoma drug met its primary endpoint with top-line results but missed its secondary endpoint of overall survival.

  6. Lilly To Present Pipeline Data On Cancer Therapies At AACR 2014

    Eli Lilly announced that it will release early-stage pipeline data on several of its targeted cancer therapies at the American Association for Cancer Research (AACR) Annual Meeting 2014 held in San Diego, CA this month.

  7. New Study Highlights Benefits Of Combining Light Scattering And Refractive Index Detectors Designed Specifically For UHPLC Applications

    Wyatt Technology Corporation, the world leader in absolute macromolecular characterization instrumentation and software, has announced the availability of a new application note which outlines the combined use of the Wyatt μDAWN multi-angle light scattering (MALS) detectorand the Optilab UT-rEX refractive index (RI) detector to measure the absolute molecular weight (or molar mass) and size of eluting species in ultra high performance liquid chromatography (UHPLC),

  8. ASI Announces The Launch Of A New Website

    Advanced Scientifics (ASI) launches a new corporate website ( providing an updated resource for its company, product, quality and employment information

  9. India's Open Source Drug Discovery Program Faces Lack Of Funding

    India's Open Source Drug Discovery Program, or OSDD, ran out of funding last week, as the ministry of science and technology did not clear the cabinet note to extend the project's funding on time. OSDD was created in 2008 in an effort to develop new drugs to treat neglected diseases, including Tuberculosis, Malaria, and Leishmaniasis.

  10. Daiichi Sankyo Partners With UCSF To Develop Neurodegenerative Drugs

    Daiichi Sankyo announced that it has entered into a drug discovery partnership with the University of California, San Francisco (UCSF) to develop new therapeutics and molecular diagnostics for a number of neurodegenerative diseases.